Health Data Collaboration for Disease Prevention
Health Data Collaboration for Disease Prevention
Description:
This collaboration involves sharing data from healthcare providers and pharmaceutical companies to monitor and prevent diseases, particularly lifestyle diseases such as diabetes and obesity.
Objectives:
• Enhance early detection and prevention of lifestyle diseases.
• Improve healthcare resource allocation and planning.
• Promote healthier lifestyles.
Socio-Economic Impact:
• Government: Reduced healthcare costs, improved public health outcomes, and a healthier population.
• Private Sector: Insights into health trends drive product development, and companies enhance their reputation by supporting public health.
Potential Datasets:
• Anonymized data on disease prevalence.
• Anonymized health records from private healthcare providers.
• Anonymized Data from pharmaceutical companies on medication usage and effectiveness.
• Anonymized data on patient responses to specific medications.
• Anonymized records of insurance claims associated with lifestyle diseases.
• Anonymized data on the usage patterns of medical devices (e.g., blood glucose monitors, fitness trackers) for monitoring lifestyle diseases.
• Aggregated data on health trends identified through big data analytics.
Potential Stakeholders:
Pharmaceutical companies. Healthcare Providers (Private Clinics and Hospitals), Health Insurance Companies, Medical Device Manufacturers, Wellness and Fitness Companies, Digital Health Platforms
Code: Health
Sustainable Development Goals (SDG):
International Best Practices:
The US CDC partners with private healthcare providers for disease monitoring, enabling early interventions and improving health outcomes.
How to get involved?
D4G Alliance initiative facilitates win-win collaboration between relevant stakeholders where privately held data are utilized to produce actionable insights for the public interest in the Emirates of Abu Dhabi.
Partner With Us !